Providing IR communications to healthcare and biotechnology sector, representing public and private companies across all therapeutic areas & development stages
Our CEO Tim Van Hauwermeiren has a clear vision for our path to redefining immunology. Watch his #JPM2022#Healthcare Conference presentation Monday at 7:30am ET to discover how we plan to advance toward #argenx2025.
Learn more: https://t.co/Jsae1jArD4
#TogetherWeDiscover
Tune into my presentation at #JPM22 to hear how @SageBiotech is striving to address critical unmet needs for people affected by #brainhealth disorders. #JPM2022
Following #JPM2022 switch to virtual we here at @SternIR are pivoting too, with virtual corporate access all week Jan 10-14 with 80+ terrific clients here. https://t.co/j59rjDj1A3
Following #JPM2022 switch to virtual we here at @SternIR are pivoting too, with virtual corporate access all week Jan 10-14 with 80+ terrific clients here https://t.co/ZQYgEsXuW8